Effect of Different Currents for Transcranial Modulation of the Sensorimotor Corticospinal Pathway in Healthy Subjects
CURRENT-Flow
2 other identifiers
interventional
14
1 country
1
Brief Summary
Transcranial modulation of the corticospinal sensorimotor pathway is a promising approach in neuroscientic functions. Among the techniques used, transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS) and the application of random noise current stand out. Objective: To compare the e stimulus, in the EEG frequency bands, on Motor Evoked Potentials (MEP) and on the functional activation of the motor cortex, assessed by Functional Near Infrared Spectroscopy (fNIRS) and pain measurements in healthy subjects subjected to a standardized algogenic stimulus. Subjects and Method: This is a randomized, double-blind, controlled and crossover clinical trial, involving the inclusion of 14 healthy male subjects, with complete secondary education, aged between 18 and 40. years. Participants will be randomized to receive Transcranial Direct Current Stimulation (tDCS), (2) Transcranial Alternating Current Stimulation (tACs), (3) Random Noise Current, (4) Simulated Stimulation Session and (5) Rest Session. Experimental conditions will take place in a standard, quiet and bright room. Assessments will include Motor Evoked Potential, Heat Pain Threshold, Motor Area Activation through metabolic activation measured by fNIRS and analysis of EEG frequency waves. After the baseline assessment, participants will undergo a session of transcranial stimulation, followed by an algogenic stimulus with water at zero degrees, immersion of the dominant hand for 1 minute, with rest intervals of 3 minutes between each of the four serial stimuli. After this stimulus session, outcome measurements will be carried out. Expected results: This clinical trial is expected to provide insights into how tDCS, tACs and random stimulation in to an algogenic stimulus. The results may contribute to the development of therapeutic or neuromodulation strategies in clinical conditions where the regulation of the cortico-spinal sensorimotor pathway is relevant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2026
CompletedStudy Start
First participant enrolled
July 15, 2026
CompletedFirst Posted
Study publicly available on registry
September 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 26, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 26, 2026
September 21, 2026
September 1, 2026
3 months
January 13, 2026
September 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Resting-State EEG Power Spectra Across Frequency Bands (Delta, Theta, Alpha, Beta 1, Beta 2, and Gamma)
Electroencephalography (EEG) will be used to quantify neuronal activity through quantitative EEG (qEEG) analysis. Resting-state EEG power spectra will be analyzed across delta, theta, alpha, beta, and gamma frequency bands, reflecting synchronized neuronal oscillations. EEG data will be recorded using a 20-electrode montage according to the international 10-20 system during an 8-minute resting-state paradigm with alternating eyes-open and eyes-closed conditions. Cortical source localization will be performed using standardized Low-Resolution Brain Electromagnetic Tomography (sLORETA).
Immediately before and immediately after the intervention.
Secondary Outcomes (5)
Corticospinal Excitability
Immediately before and immediately after the intervention.
Motor Cortex Functional Connectivity
Immediately before and immediately after the intervention.
Heat Pain Threshold
Immediately before and immediately after the intervention.
Function of the Descending Pain Inhibitory System
Immediately before and immediately after the intervention.
Cold Pressor Test Pain Tolerance
Immediately before and immediately after the intervention.
Study Arms (5)
Transcranial Direct Current Stimulation (tDCS) over motor area (M1)
ACTIVE COMPARATORParticipants receive active transcranial direct current stimulation over the primary motor cortex (M1) during the intervention sessions.
Transcranial Alternating Current Stimulation (tACS) over M1
ACTIVE COMPARATORParticipants receive active transcranial alternating current stimulation over the primary motor cortex (M1) during the intervention sessions.
Transcranial Random Noise Stimulation (tRNS) over M1
ACTIVE COMPARATORParticipants receive active transcranial random noise stimulation over the primary motor cortex (M1) during the intervention sessions.
Sham Stimulation
SHAM COMPARATORParticipants undergo sham stimulation, experiencing the same setup as active stimulation without actual current delivery.
Rest State
NO INTERVENTIONParticipants remain seated with their eyes open for 20 minutes during the rest session, without performing any other task.
Interventions
Single session of active gamma transcranial alternating current stimulation delivered for 30 minutes using a battery-powered external stimulator. Stimulation is applied through two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The stimulation frequency is 40 Hz, based on previous gamma-band transcranial alternating current stimulation (tACS) studies. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region.
Stimulation is delivered using two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The electrodes are positioned on the scalp according to the international 10-20 system. The anode is placed at position C3 (left primary motor cortex, M1) and the cathode over the ipsilateral clavicular region. The sinusoidal current intensity per channel ranges from ±2 mA. The session duration is 20 minutes.
Stimulation is delivered using two sponge electrodes mounted on a neoprene cap. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region. A random current level is generated for each sample at a sampling rate of 1280 samples per second. The random values are normally distributed, following a bell-shaped probability density function. The noise signal contains all frequencies up to half the sampling rate (maximum 640 Hz) and has no DC offset.
During the sham stimulation session, the tDCS device ramps up the current to 2 mA over 30 seconds and then is immediately turned off. This procedure mimics the sensations of active stimulation without delivering therapeutic current for the remainder of the session.
Eligibility Criteria
You may qualify if:
- Healthy male subjects aged 18-45 years, with at least a high school diploma, and not engaged in night-shift work.
You may not qualify if:
- Contraindications to transcranial stimulation include implanted medical devices in the brain, cardiac pacemakers, and cochlear implants.
- Current use of psychotropic medications.
- History of alcohol or substance abuse within the past 6 months.
- Neurological disorders, history of traumatic brain injury, or prior neurosurgery.
- Beck Depression Inventory-II (BDI-II) score \>13.
- Self-Reporting Questionnaire (SRQ) score \>7.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2026
First Posted
September 21, 2026
Study Start
July 15, 2026
Primary Completion (Estimated)
October 26, 2026
Study Completion (Estimated)
December 26, 2026
Last Updated
September 21, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
Data will be available upon request at wcaumo@hcpa.edu.br after 6 months of publication.